AA06276
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
100mg | 97% | in stock | $229.00 | $160.00 | - + | |
250mg | 97% | in stock | $336.00 | $235.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AA06276 |
Chemical Name: | 7H-Pyrrolo[2,3-d]pyrimidine-2-carboxylic acid |
CAS Number: | 1016241-64-7 |
Molecular Formula: | C7H5N3O2 |
Molecular Weight: | 163.1335 |
MDL Number: | MFCD11518909 |
SMILES: | OC(=O)c1cc2c([nH]1)ncnc2 |
7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid is a valuable building block in chemical synthesis, particularly in the pharmaceutical industry. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including potential drugs and pharmaceuticals. Its unique structure and versatile reactivity make it a crucial component in the preparation of diverse chemical compounds with important pharmacological properties.One of the primary applications of 7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid lies in its ability to undergo various transformations and functionalization reactions, enabling the introduction of different chemical groups at specific positions on the molecule. This flexibility in modification allows chemists to tailor the properties of the final products for specific biological targets or desired activities.Additionally, the presence of functional groups on 7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid provides opportunities for the formation of key bonds and structural motifs necessary for the synthesis of complex bioactive compounds. By incorporating this intermediate into synthetic routes, chemists can efficiently access structurally diverse molecules with potential pharmaceutical relevance.Overall, the strategic use of 7H-Pyrrolo[2,3-d]pyrimidine-6-carboxylic acid in chemical synthesis enables the construction of molecular scaffolds and complex structures essential for drug discovery and development efforts in the pharmaceutical industry.